Maxipime

Maxipime is a brand name of cefepime, approved by the FDA in the following formulation(s):

MAXIPIME (cefepime hydrochloride - injectable; injection)

• 
  Manufacturer: HOSPIRA INC
  
  Approval date: January 18, 1996
  
  Strength(s): EQ 1GM BASE/VIAL ^[RLD][AP], EQ 2GM BASE/VIAL ^[RLD][AP], EQ 500MG BASE/VIAL ^[RLD][AP]

Has a generic version of Maxipime been approved?

Yes. The following products are equivalent to Maxipime:

cefepime hydrochloride injectable; injection

• 
  Manufacturer: ACS DOBFAR
  
  Approval date: March 20, 2008
  
  Strength(s): EQ 1GM BASE/VIAL ^[AP], EQ 2GM BASE/VIAL ^[AP]


• 
  Manufacturer: SANDOZ
  
  Approval date: December 21, 2010
  
  Strength(s): EQ 1GM BASE/VIAL ^[AP], EQ 2GM BASE/VIAL ^[AP], EQ 500MG BASE/VIAL ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Maxipime. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Maxipime.

See also...

• Maxipime Consumer Information (Wolters Kluwer)
• Maxipime Consumer Information (Cerner Multum)
• Maxipime ADD-Vantage Consumer Information (Cerner Multum)
• Maxipime Advanced Consumer Information (Micromedex)
• Maxipime AHFS DI Monographs (ASHP)
• Cefepime Consumer Information (Wolters Kluwer)
• Cefepime Consumer Information (Cerner Multum)
• Cefepime Injection Advanced Consumer Information (Micromedex)
• Cefepime Hydrochloride AHFS DI Monographs (ASHP)